Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Diagnostic value of laboratory monitoring to predict severe hemolytic disease of the fetus and newborn in non-D and non-K-alloimmunized pregnancies.

Koelewijn JM, Slootweg YM, Folman C, van Kamp IL, Oepkes D, de Haas M.

Transfusion. 2020 Feb;60(2):391-399. doi: 10.1111/trf.15631. Epub 2019 Dec 23.

PMID:
31867744
2.

Complement C3 inhibition by compstatin Cp40 prevents intra- and extravascular hemolysis of red blood cells.

Baas I, Delvasto-Nuñez L, Ligthart P, Brouwer C, Folman C, Reis ES, Ricklin D, Lambris JD, Wouters D, de Haas M, Jongerius I, Zeerleder SS.

Haematologica. 2020 Jan 31;105(2):e57-e60. doi: 10.3324/haematol.2019.216028. Print 2020. No abstract available.

3.

A national Transfusion Register of Irregular Antibodies and Cross (X)-match Problems: TRIX, a 10-year analysis.

van Gammeren AJ, van den Bos AG, Som N, Veldhoven C, Vossen RCRM, Folman CC.

Transfusion. 2019 Aug;59(8):2559-2566. doi: 10.1111/trf.15351. Epub 2019 May 23.

PMID:
31121075
4.

Plasma thrombopoietin levels as additional tool in clinical management of thrombocytopenic neonates.

Porcelijn L, Huiskes E, Onderwater-Van Den Hoogen L, Folman CC, Zwaginga JJ, De Haas M.

Platelets. 2020;31(1):62-67. doi: 10.1080/09537104.2019.1572877. Epub 2019 Feb 13.

PMID:
30759044
5.

Complement deposition in autoimmune hemolytic anemia is a footprint for difficult-to-detect IgM autoantibodies.

Meulenbroek EM, de Haas M, Brouwer C, Folman C, Zeerleder SS, Wouters D.

Haematologica. 2015 Nov;100(11):1407-14. doi: 10.3324/haematol.2015.128991. Epub 2015 Sep 9.

6.

[Ceftriaxone-induced immune haemolytic anaemia and multi-organ failure].

Mulkens CE, van Lochem EG, Folman CC, van der Spek E, van Leeuwen HJ.

Ned Tijdschr Geneeskd. 2015;159:A8054. Dutch.

PMID:
25714764
7.

Anti-Emm in a pregnant patient--case report.

Wagner MM, van Dunné FM, Kuipers I, Thornton N, Folman CC, Ponjee GA, Oepkes D.

Vox Sang. 2014 May;106(4):385-6. doi: 10.1111/vox.12104. Epub 2013 Oct 25.

PMID:
24164348
8.

Transfusion reaction caused by anti-Vr, the first case reported.

Boonen K, van der Stokker A, Folman C, van de Kerkhof D.

Transfus Med. 2013 Jun;23(3):204-5. doi: 10.1111/tme.12017. Epub 2013 Apr 15. No abstract available.

PMID:
23581842
9.

Postnatal outcome in neonates with severe Rhesus c compared to rhesus D hemolytic disease.

Rath ME, Smits-Wintjens VE, Lindenburg IT, Folman CC, Brand A, van Kamp IL, Oepkes D, Walther FJ, Lopriore E.

Transfusion. 2013 Jul;53(7):1580-5. doi: 10.1111/j.1537-2995.2012.03937.x. Epub 2012 Nov 1.

PMID:
23113703
10.

Successful transfusion care for a patient with the Rhesus -D- phenotype and antibodies against Rh17 and two additional alloantibodies.

De Vooght KM, Demir AY, Folman CC, Schutgens RE, van Solinge WW, Kemperman H.

Ann Hematol. 2012 Jun;91(6):963-4. doi: 10.1007/s00277-011-1344-7. No abstract available.

11.

Diagnostic and therapeutic challenges of severe Rh e-specific IgA-mediated autoimmune hemolytic anemia.

Boven LA, de Haar-Holleman A, Folman CC, Kraaijenhagen RJ, Fijnheer R.

Ann Hematol. 2012 Apr;91(4):641-2. doi: 10.1007/s00277-011-1304-2. Epub 2011 Jul 30. No abstract available.

PMID:
21805111
12.

Molecular analysis of the York antigen of the Knops blood group system.

Veldhuisen B, Ligthart PC, Vidarsson G, Roels I, Folman CC, van der Schoot CE, de Haas M.

Transfusion. 2011 Jul;51(7):1389-96. doi: 10.1111/j.1537-2995.2010.02999.x. Epub 2011 Jan 7.

PMID:
21214579
13.

Donors with a rare pheno (geno) type.

Reesink HW, Engelfriet CP, Schennach H, Gassner C, Wendel S, Fontão-Wendel R, de Brito MA, Sistonen P, Matilainen J, Peyrard T, Pham BN, Rouger P, Le Pennec PY, Flegel WA, von Zabern I, Lin CK, Tsoi WC, Hoffer I, Barotine-Toth K, Joshi SR, Vasantha K, Yahalom V, Asher O, Levene C, Villa MA, Revelli N, Greppi N, Marconi M, Tani Y, Folman CC, de Haas M, Koopman MM, Beckers E, Gounder DS, Flanagan P, Wall L, Aranburu Urtasun E, Hustinx H, Niederhauser C, Flickinger C, Nance SJ, Meny GM.

Vox Sang. 2008 Oct;95(3):236-53. doi: 10.1111/j.1423-0410.2008.01084.x. No abstract available.

PMID:
19121189
14.
15.

Blood group does not correlate with disease severity in patients with Fabry disease (alpha-galactosidase A deficiency).

Linthorst GE, Folman CC, Aerts JM, Hollak CE.

Blood Cells Mol Dis. 2003 Nov-Dec;31(3):324-6.

PMID:
14636646
16.

Fetal and neonatal thrombopoietin levels in alloimmune thrombocytopenia.

Porcelijn L, Folman CC, de Haas M, Kanhai HH, Murphy MF, von dem Borne AE, Bussel JB.

Pediatr Res. 2002 Jul;52(1):105-8.

PMID:
12084855
17.

Three parameters, plasma thrombopoietin levels, plasma glycocalicin levels and megakaryocyte culture, distinguish between different causes of congenital thrombocytopenia.

van den Oudenrijn S, Bruin M, Folman CC, Bussel J, de Haas M, von dem Borne AE.

Br J Haematol. 2002 May;117(2):390-8.

PMID:
11972523
18.

Plasma thrombopoietin levels in patients with chronic renal failure.

Linthorst GE, Folman CC, van Olden RW, von dem Borne AE.

Hematol J. 2002;3(1):38-42.

PMID:
11960394
19.

The potential role of thrombopoietin in idiopathic thrombocytopenic purpura.

von dem Borne A, Folman C, van den Oudenrijn S, Linthorst G, de Jong S, de Haas M.

Blood Rev. 2002 Mar;16(1):57-9. Review.

PMID:
11913997
20.

The role of thrombopoietin in post-operative thrombocytosis.

Folman CC, Ooms M, Kuenen B B, de Jong SM, Vet RJ, de Haas M, von dem Borne AE.

Br J Haematol. 2001 Jul;114(1):126-33.

PMID:
11472357
21.

In multiple myeloma increased thrombopoietin (Tpo) production may be involved in the maintenance of platelet production.

Folman CC, de Jong CM, de Haas M, von dem Borne AE.

Eur J Haematol. 2001 May;66(5):337-41.

PMID:
11422414
22.

Analysis of the kinetics of TPO uptake during platelet transfusion.

Folman CC, de Jong SM, de Haas M, von dem Borne AE.

Transfusion. 2001 Apr;41(4):517-21.

PMID:
11316903
23.

High levels of reticulated platelets and thrombopoietin characterize fetal thrombopoiesis.

Jilma-Stohlawetz P, Homoncik M, Jilma B, Folman CC, von dem Borne AE, Bernaschek G, Deutinger J, Ulm B, Eppel W, Panzer S.

Br J Haematol. 2001 Feb;112(2):466-8.

PMID:
11167848
24.

Effects of anticoagulation on thrombopoietin release during endotoxemia.

Jilma-Stohlawetz P, Folman CC, von dem Borne AE, Pernerstorfer T, Hollenstein U, Knechtelsdorfer M, Eichler HG, Jilma B.

J Lab Clin Med. 2001 Jan;137(1):64-9.

PMID:
11150025
25.

Defective c-Mpl signaling in the syndrome of thrombocytopenia with absent radii.

Ballmaier M, Schulze H, Cremer M, Folman CC, Strauss G, Welte K.

Stem Cells. 1998;16 Suppl 2:177-84.

26.

Mutations in the thrombopoietin receptor, Mpl, in children with congenital amegakaryocytic thrombocytopenia.

van den Oudenrijn S, Bruin M, Folman CC, Peters M, Faulkner LB, de Haas M, von dem Borne AE.

Br J Haematol. 2000 Aug;110(2):441-8.

PMID:
10971406
27.

Increase in glycocalicin levels in platelet concentrates stored in plasma or synthetic medium for 8 days: comparison with other platelet activation markers.

Kostelijk EH, Folman CC, Gouwerok CW, Kramer CM, Verhoeven AJ, de Korte D.

Vox Sang. 2000;79(1):21-6.

PMID:
10971210
28.

Platelets release thrombopoietin (Tpo) upon activation: another regulatory loop in thrombocytopoiesis?

Folman CC, Linthorst GE, van Mourik J, van Willigen G, de Jonge E, Levi M, de Haas M, von dem Borne AE.

Thromb Haemost. 2000 Jun;83(6):923-30.

PMID:
10896250
29.

Serum levels of thrombopoietin, IL-11, and IL-6 in pediatric thrombocytopenias.

Cremer M, Schulze H, Linthorst G, Folman CC, Wehnert S, Strauss G, von dem Borne AE, Welte K, Ballmaier M.

Ann Hematol. 1999 Sep;78(9):401-7.

PMID:
10525827
30.

Effects of endotoxemia on thrombopoiesis in men.

Stohlawetz P, Folman CC, von dem Borne AE, Pernerstorfer T, Eichler HG, Panzer S, Jilma B.

Thromb Haemost. 1999 Apr;81(4):613-7.

PMID:
10235449
31.

Thrombopoietin: its role in platelet disorders and as a new drug in clinical medicine.

von dem Borne AE, Folman C, Linthorst GE, Porcelijn L, van den Oudenrijn S, van der Schoot E, de Haas M.

Baillieres Clin Haematol. 1998 Jun;11(2):427-45. Review. No abstract available.

PMID:
10097818
32.

Thrombopoietin and its receptor: structure, function and role in the regulation of platelet production.

von dem Borne AE, Folman C, Linthorst GE, Porcelijn L, van den Oudenrijn S, van der Schoot E, de Haas M.

Baillieres Clin Haematol. 1998 Jun;11(2):409-26. Review. No abstract available.

PMID:
10097817
33.

Platelet: transporter of vascular endothelial growth factor.

Verheul HM, Hoekman K, Luykx-de Bakker S, Eekman CA, Folman CC, Broxterman HJ, Pinedo HM.

Clin Cancer Res. 1997 Dec;3(12 Pt 1):2187-90.

34.

The diagnostic value of thrombopoietin level measurements in thrombocytopenia.

Porcelijn L, Folman CC, Bossers B, Huiskes E, Overbeeke MA, v d Schoot CE, de Haas M, von dem Borne AE.

Thromb Haemost. 1998 Jun;79(6):1101-5.

PMID:
9657431
35.

Sensitive measurement of thrombopoietin by a monoclonal antibody based sandwich enzyme-linked immunosorbent assay.

Folman CC, von dem Borne AE, Rensink IH, Gerritsen W, van der Schoot CE, de Haas M, Aarden L.

Thromb Haemost. 1997 Oct;78(4):1262-7.

PMID:
9364995
36.

The Arg633His substitution responsible for the private platelet antigen Gro(a) unravelled by SSCP analysis and direct sequencing.

Simsek S, Folman C, van der Schoot CE, von dem Borne AE.

Br J Haematol. 1997 May;97(2):330-5.

PMID:
9163597
37.

Rapid diagnosis of schistosomiasis by antigen detection in urine with a reagent strip.

van Etten L, Folman CC, Eggelte TA, Kremsner PG, Deelder AM.

J Clin Microbiol. 1994 Oct;32(10):2404-6.

Supplemental Content

Loading ...
Support Center